Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
HLN · NYSE
- Prev Close
- $9.78
- Market Cap
- $44.22B
- Open
- —
- Trailing P/E
- —
- Day Range
- $9.96 - $9.79
- 52W Range
- $11.28 - $8.65
- Forward P/E
- —
- EPS
- —
- Volume
- 6.02M
- Dividend Yield
- —
About Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
Haleon sells branded over-the-counter consumer-health products, including Advil, Sensodyne, Centrum, Panadol and Voltaren. It makes money through sales of branded consumer-health products. The supplied evidence identifies North America and emerging markets as areas of performance, but does not provide a segment breakdown or the contribution of each region or product category. Its customers are consumers seeking pain relief, oral care, vitamins and supplements, and related everyday health products. Haleon operates a multi-brand portfolio rather than a single-product business. The evidence does not state current revenue, employee count, geographic footprint, or other scale measures.
Notable Price Movement
- Aug 3-7$9.780.91%
Haleon fell 4.77% over the supplied period, from $10.27 on July 28 to $9.78 on August 4. Trading was initially steady, with a marginal gain to $10.28 on July 29, before the stock declined to $10.11 on July 30 and $9.87 on July 31. It then extended the retreat on both August 3 and August 4, losing $0.07 and $0.02, respectively. The evidence does not tie those moves to a specific announcement, analyst action, or reported financial figure. The supplied articles discuss Haleon’s half-year results and second-quarter organic growth, but provide no publication dates or evidence that they drove trading. No broader market catalyst is supplied, so the week is best described as an unexplained decline.
Stories & Analysis
Haleon H1 Earnings Call Highlights
Supplier Of Advil, Haleon Reports Half-Year 2026 ResultsIs Kenvue Stock Attractive After Margin Gains and Deal UncertaintyKenvue Benefits From Consumer Health Trends and Margin Expansion